The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients

por Pollack, Seth M.
Publicado 2017

Pushing forward in sarcoma with a new TCR targeting NY-ESO-1

por Al-Marayaty, Rusul, Pollack, Seth M.
Publicado 2023

Optimising Cancer Vaccine Design in Sarcoma

por Pender, Alexandra, Jones, Robin L., Pollack, Seth
Publicado 2018

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib

por Rajendra, Rajeev, Jones, Robin L, Pollack, Seth M
Publicado 2013

Pazopanib in the management of advanced soft tissue sarcomas

por Cranmer, Lee D, Loggers, Elizabeth T, Pollack, Seth M
Publicado 2016

Targeting cancer testis antigens in synovial sarcoma

por Mitchell, Geoffrey, Pollack, Seth M, Wagner, Michael J
Publicado 2021

Trabectedin in Soft Tissue Sarcomas

por Petek, Bradley J., Loggers, Elizabeth T., Pollack, Seth M., Jones, Robin L.
Publicado 2015

Phase III Soft Tissue Sarcoma Trials: Success or Failure?

por Lee, Alexander T. J., Pollack, Seth M., Huang, Paul, Jones, Robin L.
Publicado 2017

Propranolol for the treatment of vascular sarcomas

por Wagner, Michael J, Cranmer, Lee D, Loggers, Elizabeth T, Pollack, Seth M
Publicado 2018

Immune-Based Therapies for Sarcoma

por Pollack, Seth M., Loggers, Elizabeth T., Rodler, Eve T., Yee, Cassian, Jones, Robin L.
Publicado 2011

Systemic therapy in primary angiosarcoma of the spleen

por Ferreira, Bruna Pellini, Rodler, Eve T., Loggers, Elizabeth T., Pollack, Seth M., Jones, Robin L.
Publicado 2012

Drug repositioning in sarcomas and other rare tumors

por Lee, Alex T.J., Huang, Paul H., Pollack, Seth M., Jones, Robin L.
Publicado 2016

Targeting gastrointestinal stromal tumors: the role of regorafenib

por Schroeder, Brett, Li, Zula, Cranmer, Lee D, Jones, Robin L, Pollack, Seth M
Publicado 2016

Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma

por Jones, Robin L., Katz, Daniela, Loggers, Elizabeth T., Davidson, Darin, Rodler, Eve T., Pollack, Seth M.
Publicado 2017

Advances in the treatment of soft tissue sarcoma: focus on eribulin

por Koliou, Panagiotis, Karavasilis, Vasilios, Theochari, Maria, Pollack, Seth M, Jones, Robin L, Thway, Khin
Publicado 2018

The Imaging and Pathological Features of Metastatic Leiomyosarcoma in the Gallbladder

por Guo, Yi, Chen, Eleanor, Davidson, Darin J., Pillarisetty, Venu G., Jones, Robin L., Pollack, Seth M.
Publicado 2016

Response to PD1 inhibition in conventional chondrosarcoma

por Wagner, Michael J., Ricciotti, Robert W., Mantilla, Jose, Loggers, Elizabeth T., Pollack, Seth M., Cranmer, Lee D.
Publicado 2018

Multiple Liver Abscess Formation and Primary Gastrointestinal Stromal Tumor

por E. Chang, Amy, N. Mann, Gary, Hoch, Benjamin, T. Loggers, Elizabeth, M. Pollack, Seth, Kolokythas, Orpheus, L. Jones, Robin
Publicado 2013

Durable tumor regression in highly refractory metastatic KIT/PDGFRA wild-type GIST following treatment with nivolumab

por Schroeder, Brett A., Kohli, Karan, O’Malley, Ryan B., Kim, Theresa S., Jones, Robin L., Pierce, Robert H., Pollack, Seth M.
Publicado 2020

Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume center

por Eastman, Boryana M., Hippe, Daniel S., Wootton, Landon S., Nyflot, Matthew J., Thompson, Matthew J., Pollack, Seth M., Kim, Edward, Spraker, Matthew B.
Publicado 2021